Predictors of efficacy, mucosal healing and dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary

Kiss, L. and Miheller, P. and Molnár, T. and Lakatos, L. and Vincze, Á. and Palatka, K. and Gasztonyi, B. and Salamon, Á. and Horvath, G. and Farkas, K. and Szamosi, T. and Banai, J. and Tulassay, Z. and Papp, M. and Lakatos, P. (2011) Predictors of efficacy, mucosal healing and dose intensification at 12-months of adalimumab therapy in patients with Crohn's disease. National data from Hungary. Zeitschrift für Gastroenterologie, 49. ISSN 0044-2771

Text ZG11.49-A39.pdf - Accepted Version Restricted to Registered users only Download (658kB) | Request a copy

Actions (login required)

Edit Item